Patil Automation set for NSE SME debut today. GMP hints at modest premium
Live Events
(You can now subscribe to our
(You can now subscribe to our ETMarkets WhatsApp channel
Pune-based Patil Automation is set to list on the NSE SME platform today after seeing overwhelming investor demand during its Rs 69.61 crore IPO . The issue was subscribed an impressive 101.42 times overall, driven by robust interest from non-institutional investors (NII) who bid 258 times their quota. Retail investors subscribed 44.77 times, while the Qualified Institutional Buyer (QIB) category was booked 82.92 times.Ahead of the listing, the grey market premium (GMP) for Patil Automation shares is hovering around ₹31, indicating a listing price of Rs 151 per share—nearly 26% higher than the issue price of Rs 120. While GMPs are unofficial and not always accurate indicators, the premium reflects positive sentiment among investors.The IPO consisted entirely of a fresh issue of 58 lakh shares. Anchor investors had pumped in Rs 19.81 crore ahead of the IPO opening, with 16.51 lakh shares allocated at the upper price band. The funds raised will be used primarily to set up a new manufacturing facility and repay a portion of the company's borrowings.Founded in 2015, Patil Automation provides automation and robotics solutions across industries including automotive, electronics, and general engineering.Its product range includes robotic welding systems, automated assembly lines, conveyor systems, and AI-based vision inspection systems. The company operates five facilities and has over 500 personnel including contractual workers.For FY25, the company posted a net profit of Rs 11.70 crore on a revenue of Rs 122 crore, with PAT margins at 9.91% and ROE at 27.28%. The IPO valued the firm at a post-issue P/E of around 22.4x.Given the strong subscription figures and current GMP, the listing is likely to be positive, though post-listing performance may depend on broader market trends and investor appetite for SME stocks.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
20 minutes ago
- News18
Influx Healthtech IPO Allotment: A Step-By-Step Guide To Check Status Online Today, Know Latest GMP
Last Updated: According to market observers, the GMP of the Influx Healthtech IPO is 22.92%, indicating decent listing gains for investors. Influx Healthtech IPO Allotment: The initial public offering of Influx Healthtech has received a whopping 201.35 times subscription, indicating huge interest from investors. Investors are now eagerly awaiting its allotment even its latest GMP shows a strong 22.92% listing gains. The allotment of the Influx Healthtech IPO is expected to be finalised today, Monday, June 23, in the evening. Once the IPO allotment is finalised, investors will start receiving bank debit messages, most probably in the evening. They can also check their allotment status on the websites of the NSE as well as registrar Maashitla Securities Private Limited. The allotment is expected to be finalised in the evening today, Friday, June 20. The allotment status can be checked by following these steps: Step 1: Visit Maashitla Securities' portal — Step 2: Under 'Select Company', choose 'Influx Healthtech Ltd'. Importantly, if the company's name is not visible in the drop-down list, it means the allotment has not been finalised yet. According to market observers, the GMP of the Influx Healthtech IPO is 22.92%, indicating decent listing gains for investors. The GMP is based on market sentiments and keeps changing. 'Grey market premium' indicates investors' readiness to pay more than the issue price. Influx Healthtech IPO Listing Date The shares of Influx Healthtech Ltd will be listed on the NSE Emerge on June 25. The Influx Healthtech IPO was open for subscription between June 18 and June 20. It is a book-built issue worth Rs 58.57 crore, comprising a fresh issue of 50 lakh equity shares worth Rs 48 crore and an offer for sale of 11 lakh shares aggregating to Rs 10.56 crore. On the final day of bidding on Friday, the SME IPO received an overwhelming 201.35 times subscription, garnering bids for 81,71,71,200 shares as against 40,58,400 shares on offer. The retail and NII participation stood at 117.68 times and 481.10 times, respectively. Its qualified institutional buyer (QIB) category got a 137.87 times subscription. The price of the Influx Healthtech IPO was fixed at Rs 96 apiece. Influx Healthtech Ltd's revenue increased 5% and its profit after tax (PAT) rose 19% between the financial year ending with March 31, 2025, and March 31, 2024. Rarever Financial Advisors Pvt Ltd is the book-running lead manager of the Influx Healthtech IPO, while Maashitla Securities Private Limited is the registrar for the issue. The market maker for Influx Healthtech IPO is R K Stock Holding Private Limited. Influx Healthtech Ltd, founded in September 2020, is a healthcare-focused CDMO with three manufacturing units in Thane, producing tablets, capsules, powders, liquid orals, and softgels.
India.com
23 minutes ago
- India.com
Good news for Anil Ambani, another company settles Rs 2730000000 loan of…, with…
Anil Ambani was already in the news for settling down the debt of his many companies. Now once again it has settled the debt with another company. In a recent exchange filing it stated that it has fully settled a Rs 273-crore loan, including interest, owed by its wholly owned subsidiary JR Toll Road Pvt Ltd (JRTR) to Yes Bank Ltd. It stated, '' A wholly owned subsidiary of the Company (along with the Company as Corporate Guarantor), has entered into an addendum to the Settlement Agreement today with Yes Bank Limited (YBL) for the entire outstanding debt obligation of ~INR 273 crore (including interest) owed by JRTR to YBL, and has duly paid the entire settlement amount.'' Anil Ambani Company Debt Reduction Debt reduction has become a primary focus for Anil Ambani. Reliance Infrastructure: Paid off Rs 3,300 crore of debt in FY 2025, becoming debt-free. Rosa Power Supply Company: Cleared Rs 485 crore of debt, achieving debt-free status. Reliance Power: Settled a loan of Rs 3,872 crore earlier. JR Toll Road Pvt Ltd, a special purpose vehicle established by Reliance Infrastructure, is responsible for the development, operation, and maintenance of a 52-kilometer segment of National Highway 11, connecting Jaipur and Reengus in Rajasthan. The project was executed under the Design-Build-Finance-Operate-Transfer (DBFOT) model, featuring a highway expansion from four to six lanes. Operations commenced in 2013, coinciding with the start of toll collection.
Hindustan Times
24 minutes ago
- Hindustan Times
Watch with Kannada numerals and Karnataka's iconic crest goes viral: 'Decolonize your mind'
BJP MP Tejasvi Surya criticizes Karnataka's Rs 18,000 crore tunnel road project, calling it unscientific and financially unsound. He questions the project's feasibility, high toll costs, and potential public fund drain, challenging the government's transportation strategy.
